A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck Cancer.
Saved in:
| Title: | A Phase 2 Feasibility Study Combining Pembrolizumab and Metformin in patients with Metastatic Head and Neck Cancer. |
|---|---|
| Authors: | Zamulko O; University of Cincinnati Cincinnati, Ohio United States., Nusbaum S; University of Cincinnati Cincinnati, OH United States., Osterburg A; University of Cincinnati Cincinnati, OH United States., Crist M; University of Cincinnati Cincinnati, OH United States., Lehn M; University of Cincinnati Cincinnati, OH United States., Monroe I; University of Cincinnati Cincinnati, OH United States., Romano A; University of Cincinnati Cincinnati, OH United States., Allen CL; University of Cincinnati Cincinnati, OH United States., Forsythe A; University of Cincinnati Medical Center Cincinnati, Ohio United States., Riaz MK; University of Cincinnati Cincinnati, OH United States., Lemmon C; University of Cincinnati Medical Center Cincinnati, Ohio United States., Takiar V; University of Cincinnati Cincinnati, OH United States., Pan J; University of Cincinnati Cincinnati, OH United States., Rai SN; University of Cincinnati Cincinnati, OH United States., Borchers M; University of Cincinnati Cincinnati, OH United States., El-Gamal D; University of Cincinnati Medical Center Cincinnati, OH United States., Wise-Draper T; University of Cincinnati Cincinnati, OH United States. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 Jun 25. Date of Electronic Publication: 2026 Jun 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
